Safety Review: Squalene and Thimerosal in Vaccines
Therapie, 65 6 (2010) 533-541
Publié en ligne : 2010-12-23
Article cité par
La fonctionnalité Article cité par… liste les citations d'un article. Ces citations proviennent de la base de données des articles de EDP Sciences, ainsi que des bases de données d'autres éditeurs participant au programme CrossRef Cited-by Linking Program. Vous pouvez définir une alerte courriel pour être prévenu de la parution d'un nouvel article citant " cet article (voir sur la page du résumé de l'article le menu à droite).
Article cité :
Citations de cet article :
Research progress on emulsion vaccine adjuvants
Zhuanqing Huang, Hui Gong, Qi Sun, Jinjin Yang, Xiaochuan Yan and Fenghua XuHeliyon 10 (3) e24662 (2024)
https://doi.org/10.1016/j.heliyon.2024.e24662
Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives
Vanitha Sampath, Grace Rabinowitz, Mihir Shah, Surabhi Jain, Zuzana Diamant, Milos Jesenak, Ronald Rabin, Stefan Vieths, Ioana Agache, Mübeccel Akdis, Domingo Barber, Heimo Breiteneder, Sharon Chinthrajah, Tomas Chivato, William Collins, Thomas Eiwegger, Katharine Fast, Wytske Fokkens, Robyn E. O'Hehir, Markus Ollert, Liam O'Mahony, Oscar Palomares, Oliver Pfaar, Carmen Riggioni, Mohamed H Shamji, et al.Allergy 76 (6) 1640 (2021)
https://doi.org/10.1111/all.14840
Association between vaccine adjuvant effect and pre-seasonal immunity. Systematic review and meta-analysis of randomised immunogenicity trials comparing squalene-adjuvanted and aqueous inactivated influenza vaccines
Walter E.P. Beyer, Abraham M. Palache, Leslie A. Reperant, Mimoun Boulfich and Albert D.M.E. OsterhausVaccine 38 (7) 1614 (2020)
https://doi.org/10.1016/j.vaccine.2019.12.037
Utilization of marine by-products for the recovery of value-added products
Fereidoon Shahidi, Vamadevan Varatharajan, Han Peng and Ruchira SenadheeraJournal of Food Bioactives 10 (2019)
https://doi.org/10.31665/JFB.2019.6184
Vaccines: Are they Worth a Shot?
Andrea GrignolioVaccines: Are they Worth a Shot? 41 (2018)
https://doi.org/10.1007/978-3-319-68106-1_3
https://doi.org/10.1002/9781119042280.ch9
Immunoengineering through cancer vaccines – A personalized and multi-step vaccine approach towards precise cancer immunity
Lien Lybaert, Karim Vermaelen, Bruno G. De Geest and Lutz NuhnJournal of Controlled Release 289 125 (2018)
https://doi.org/10.1016/j.jconrel.2018.09.009
Environmental factors in the development of autism spectrum disorders
L.A. Sealey, B.W. Hughes, A.N. Sriskanda, et al.Environment International 88 288 (2016)
https://doi.org/10.1016/j.envint.2015.12.021
Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial
Ivan Fan-Ngai Hung, Anna Jinxia Zhang, Kelvin Kai-Wang To, et al.The Lancet Infectious Diseases 16 (2) 209 (2016)
https://doi.org/10.1016/S1473-3099(15)00354-0
Acute Lung Injury Accompanying Alveolar Hemorrhage Associated with Flu Vaccination in the Elderly
Etsuko Satoh, Takahito Nei, Shinichi Kuzu, et al.Internal Medicine 54 (24) 3193 (2015)
https://doi.org/10.2169/internalmedicine.54.4894
A physiologically-based pharmacokinetic (PBPK) model of squalene-containing adjuvant in human vaccines
Million A. Tegenge and Robert J. MitkusJournal of Pharmacokinetics and Pharmacodynamics 40 (5) 545 (2013)
https://doi.org/10.1007/s10928-013-9328-y
AF03, An Alternative Squalene Emulsion‐Based Vaccine Adjuvant Prepared by a Phase Inversion Temperature Method
Marie‐Françoise Klucker, François Dalençon, Patricia Probeck and Jean HaenslerJournal of Pharmaceutical Sciences 101 (12) 4490 (2012)
https://doi.org/10.1002/jps.23311
Autoimmune disorders after immunisation with Influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review
Alina Isai, Julie Durand, Steven Le Meur, Ana Hidalgo-Simon and Xavier KurzVaccine 30 (49) 7123 (2012)
https://doi.org/10.1016/j.vaccine.2012.09.032
Safety of Thimerosal in Vaccines: for Whom and How Many Doses?
José G. DóreaThérapie 66 (2) 95 (2011)
https://doi.org/10.2515/therapie/2011027